Hahn & Company and Lutronic CEO Haelyung Hwang Launch Tender Offer to Acquire Lutronic
June 14, 2023
South Korean private equity firm Hahn & Company has signed definitive agreements with Lutronic founder and CEO Haelyung Hwang to jointly launch a tender offer for all remaining shares of Lutronic for KRW957.0 billion (US$735.9 million). Lutronic is a South Korea–based maker of aesthetic medical devices with 2022 revenues of over KRW264 billion and a growing global presence, particularly in the United States and Europe.
- Buyers
- Hahn & Company, Haelyung Hwang
- Targets
- Lutronic
- Industry
- Medical Devices
- Location
- South Korea
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Hahn & Company Acquires Cynosure and Merges It with Lutronic to Form Cynosure Lutronic
January 19, 2024
Medical Devices
Hahn & Company completed the acquisition of Cynosure and has combined it with Lutronic (which Hahn had recently acquired) under the newly formed parent Cynosure Lutronic, Inc. The merger creates a global leader in energy‑based medical aesthetic systems with an expanded product portfolio, R&D capabilities and a broader international commercial footprint.
-
Hahn & Co. and Hana Financial Group Buy H-Line Shipping for 1.8 Trillion Won
May 24, 2020
Transportation
South Korea’s private equity firm Hahn & Co. and Hana Financial Group have agreed to buy a 100% stake in H-Line Shipping for 1.8 trillion won (~$1.45bn). The deal is structured as a leveraged buyout via a project fund (about 45% financed with debt) and is intended to move the shipping company’s ownership to long-term investors while supporting consolidation and growth in Hahn & Co.’s shipping platform.
-
Platinum Equity Acquires Majority Interest in Hop Lun
June 20, 2022
Manufacturing
Platinum Equity has acquired a controlling stake in Hong Kong-headquartered lingerie and swimwear manufacturer Hop Lun from founder Erik Ryd, who retained a significant ownership stake. The transaction, led by Platinum's Singapore investment team, positions Hop Lun — a global designer and manufacturer employing over 30,000 with production in Bangladesh, China, Ethiopia and Indonesia — for accelerated organic growth, strategic M&A and sustainability initiatives. Financial terms were not disclosed.
-
THL Partners Acquires Majority Stake in Red Nucleus from The Riverside Company
October 17, 2024
Healthcare Services
THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.
-
Hologic Acquires Gynesonics
January 6, 2025
Medical Devices
Hologic has completed the acquisition of Gynesonics for approximately $350 million. The purchase adds the Sonata System — a minimally invasive intrauterine ultrasound-guided radiofrequency ablation platform for treating uterine fibroids — to Hologic's portfolio, expanding its capabilities in women's health surgical solutions.
-
Hahn & Co. Acquires SKC's Fine Ceramics Business (Solmics)
February 2, 2024
Manufacturing
Hahn & Co. has acquired 100% of SKC's fine ceramics business for 360 billion won (about $270 million). The acquired business, renamed Solmics, produces high‑purity quartz and silicon‑carbide consumables for advanced semiconductor manufacturing and will operate under Hahn & Co.'s ownership to expand its position in the global semiconductor materials market.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.